This mini-review discusses the evolution of fluorescence as a tool to study living cells and tissues in vitro and the present role of fluorescent protein biosensors (FPBs) in microphysiological systems (MPSs). FPBs allow the measurement of temporal and spatial dynamics of targeted cellular events involved in normal and perturbed cellular assay systems and MPSs in real time. FPBs evolved from fluorescent analog cytochemistry (FAC) that permitted the measurement of the dynamics of purified proteins covalently labeled with environmentally insensitive fluorescent dyes and then incorporated into living cells, as well as a large list of diffusible fluorescent probes engineered to measure environmental changes in living cells. In parallel, a wide range of fluorescence microscopy methods were developed to measure the chemical and molecular activities of the labeled cells, including ratio imaging, fluorescence lifetime, total internal reflection, 3D imaging, including super-resolution, as well as high-content screening. FPBs evolved from FAC by combining environmentally sensitive fluorescent dyes with proteins in order to monitor specific physiological events such as post-translational modifications, production of metabolites, changes in various ion concentrations, and the dynamic interaction of proteins with defined macromolecules in time and space within cells. Original FPBs involved the engineering of fluorescent dyes to sense specific activities when covalently attached to particular domains of the targeted protein. The subsequent development of fluorescent proteins (FPs), such as the green fluorescent protein, dramatically accelerated the adoption of studying living cells, since the genetic “labeling” of proteins became a relatively simple method that permitted the analysis of temporal–spatial dynamics of a wide range of proteins. Investigators subsequently engineered the fluorescence properties of the FPs for environmental sensitivity that, when combined with targeted proteins/peptides, created a new generation of FPBs. Examples of FPBs that are useful in MPS are presented, including the design, testing, and application in a liver MPS.
WikswoJPCurtisELEagletonZEEvansBCKoleAHofmeisterLHMatloffWJ. Scaling and systems biology for integrating multiple organs-on-a-chip. Lab Chip2013; 13: 3496–511.
3.
WikswoJP. The relevance and potential roles of microphysiological systems in biology and medicine. Exp Biol Med2014; 239: 1061–72.
4.
SchwartzRETrehanKAndrusLSheahanTPPlossADuncanSARiceCMBhatiaSN. Modeling hepatitis C virus infection using human induced pluripotent stem cells. Proc Natl Acad Sci USA2012; 109: 2544–8.
5.
Wikswo JP (ed). Annual thematic issue: the biology and medicine of microphysiological systems [Special Issue]. Exp Biol Med 2014;239:1061–1072.
6.
GiulianoKAPostPLHahnKMTaylorDL. Fluorescent protein biosensors: measurement of molecular dynamics in living cells. Annu Rev Biophys Biomol Struct1995; 24: 405–34.
7.
Giuliano KA, Taylor DL, Waggoner AS. Reagents to measure and manipulate cell functions. High content screening. Springer, New York, NY, 2006, pp.141–63.
8.
SewardHEBagshawCR. The photochemistry of fluorescent proteins: implications for their biological applications. Chem Soc Rev2009; 38: 2842–51.
9.
ZhangJCampbellRETingAYTsienRY. Creating new fluorescent probes for cell biology. Nat Rev Mol Cell Biol2002; 3: 906–18.
10.
ProvenzanoPPEliceiriKWKeelyPJ. Multiphoton microscopy and fluorescence lifetime imaging microscopy (FLIM) to monitor metastasis and the tumor microenvironment. Clin Exp Metastasis2009; 26: 357–70.
GreavesPWilliamsAEveM. First dose of potential new medicines to humans: how animals help. Nat Rev Drug Discov2004; 3: 226–36.
13.
HoltMPJuC. Mechanisms of drug-induced liver injury. AAPS J2006; 8: E48–54.
14.
BaleSSVernettiLSenutovitchNJindalRHegdeMGoughAMcCartyWJBakanABhushanAShunTYGolbergIDeBiasioRUstaOBTaylorDLYarmushML. In vitro platforms for evaluating liver toxicity. Exp Biol Med2014; 239: 1180–91.
15.
Vernetti LA, Senutovtich N, Boltz R, DeBiasio R, Shun TY, Gough A, Taylor DL. A human liver microphysiology platform for investigating physiology, drug safety, and disease models. Exp Bio Med 2015; epub ahead of print.
16.
BhushanASenutovitchNBaleSSMcCartyWJHegdeMJindalRGolbergIBerk UstaOYarmushMLVernettiLGoughABakanAShunTYDeBiasioRLansing TaylorD. Towards a three-dimensional microfluidic liver platform for predicting drug efficacy and toxicity in humans. Stem Cell Res Ther2013; 4: S16–S16.
17.
TaylorDLWangYL. Molecular cytochemistry: incorporation of fluorescently labeled actin into living cells. Proc Natl Acad Sci USA1978; 75: 857–61.
18.
FisherGWConradPADeBiasioRLTaylorDL. Centripetal transport of cytoplasm, actin, and the cell surface in lamellipodia of fibroblasts. Cell Motil Cytoskeleton1988; 11: 235–47.
19.
TaylorDLAmatoPALuby-PhelpsKMcNeilP. Fluorescent analog cytochemistry. Trends Biochem Sci1984; 9: 88–91.
20.
TaylorDLWangYL. Fluorescently labelled molecules as probes of the structure and function of living cells. Nature1980; 284: 405–10.
21.
Spence MT, Johnson ID. The molecular probes handbook: a guide to fluorescent probes and labeling technologies. Life Technologies Corporation, Grand Island, NY, 2010.
22.
GiulianoKNederlofMDeBiasioRLanniFWaggonerATaylorDMulti-mode light microscopy. In: HermanBJacobsonK (eds). Optical microscopy for biology, New York: Wiley-Liss, 1990, pp. 543–57.
23.
TaylorDLNederlofMLanniFWaggonerAS. The new vision of light microscopy. Am Scientist1992; 80: 22–35.
24.
Tsien R, Waggoner A. Fluorophores for confocal microscopy. In: Pawley J (ed) Handbook of biological confocal microscopy. Springer, New York, NY, US, 1995, pp.267–79.
25.
YengoCMBergerCL. Fluorescence anisotropy and resonance energy transfer: powerful tools for measuring real time protein dynamics in a physiological environment. Curr Opin Pharmacol2010; 10: 731–7.
26.
GradinaruCCMarushchakDOSamimMKrullUJ. Fluorescence anisotropy: from single molecules to live cells. Analyst2010; 135: 452–9.
27.
HooverEESquierJA. Advances in multiphoton microscopy technology. Nat Photon2013; 7: 93–101.
LuoWHeKXiaTFangX. Single-molecule monitoring in living cells by use of fluorescence microscopy. Anal Bioanal Chem2013; 405: 43–9.
30.
MatsudaTNagaiT. Quantitative measurement of intracellular protein dynamics using photobleaching or photoactivation of fluorescent proteins. Microscopy2014; 63: 403–8.
31.
MiyawakiA. Development of probes for cellular functions using fluorescent proteins and fluorescence resonance energy transfer. Ann Rev Biochem2011; 80: 357–73.
32.
Padilla-ParraSTramierM. FRET microscopy in the living cell: different approaches, strengths and weaknesses. Bioessays2012; 34: 369–76.
33.
BrightGRFisherGWRogowskaJTaylorDL. Fluorescence ratio imaging microscopy: temporal and spatial measurements of cytoplasmic pH. J Cell Biol1987; 104: 1019–33.
34.
HahnKDeBiasioRTaylorDL. Patterns of elevated free calcium and calmodulin activation in living cells. Nature1992; 359: 736–8.
35.
TaylorDLWooESGiulianoKA. Real-time molecular and cellular analysis: the new frontier of drug discovery. Curr Opin Biotechnol2001; 12: 75–81.
KusumiATsunoyamaTAHirosawaKMKasaiRSFujiwaraTK. Tracking single molecules at work in living cells. Nat Chem Biol2014; 10: 524–32.
38.
39.
GiulianoKADeBiasioRLDunlayRTGoughAVoloskyJMZockJPavlakisGNTaylorDL. High-content screening: a new approach to easing key bottlenecks in the drug discovery process. J Biomol Screen1997; 2: 249–59.
40.
GiulianoKAGoughAHTaylorDLVernettiLAJohnstonPA. Early safety assessment using cellular systems biology yields insights into mechanisms of action. J Biomol Screen2010; 15: 783–97.
41.
GiulianoKAHaskinsJRTaylorDL. Advances in high content screening for drug discovery. Assay Drug Dev Technol2003; 1: 565–77.
42.
TaylorDL. A personal perspective on high-content screening (HCS): from the beginning. J Biomol Screen2010; 15: 720–5.
43.
GoughAHChenNShunTYLezonTRBoltzRCReeseCEWagnerJVernettiLAGrandisJRLeeAVSternAMSchurdakMETaylorDL. Identifying and quantifying heterogeneity in high content analysis: application of heterogeneity indices to drug discovery. PLoS One2014; 9: e102678–e102678.
44.
GoughALezonTFaederJRChennubhotlaCMurphyRFCritchley-ThorneRTaylorDLHigh content analysis with cellular and tissue systems biology: a bridge between cancer cell biology and tissue-based diagnostics. In: MendelsohnJHowleyPMIsraelMAGrayJWThompsonCB (eds). The molecular basis of cancer, 4th ed. New York, NY: Elsevier, 2014.
45.
Thompson R. Protein-based biosensors with polarization transduction. In: Geddes C, Lakowicz J (eds) Advanced concepts in fluorescence sensing. Topics in fluorescence spectroscopy. 10: Springer, New York, NY, US, 2005, pp.1–19.
46.
PostPLDeBiasioRLTaylorDL. A fluorescent protein biosensor of myosin II regulatory light chain phosphorylation reports a gradient of phosphorylated myosin II in migrating cells. Mol Biol Cell1995; 6: 1755–68.
47.
DeBiasioRLLaRoccaGMPostPLTaylorDL. Myosin II transport, organization, and phosphorylation: evidence for cortical flow/solation-contraction coupling during cytokinesis and cell locomotion. Mol Biol Cell1996; 7: 1259–82.
48.
HahnKMWaggonerASTaylorDL. A calcium-sensitive fluorescent analog of calmodulin based on a novel calmodulin-binding fluorophore. J Biol Chem1990; 265: 20335–45.
GiulianoKPremkumarDTaylorDL. Optimal characteristics of protein-protein interaction biosensors for cellular systems biology profiling. High content screening: science, techniques and applications, Hoboken, NJ: John Wiley, 2007, pp. 371–87.
51.
ChalfieMTuYEuskirchenGWardWWPrasherDC. Green fluorescent protein as a marker for gene expression. Science1994; 263: 802–5.
52.
FrommerWBDavidsonMWCampbellRE. Genetically encoded biosensors based on engineered fluorescent proteins. Chem Soc Rev2009; 38: 2833–41.
53.
MiyawakiALlopisJHeimRMcCafferyJMAdamsJAIkuraMTsienRY. Fluorescent indicators for Ca2+ based on green fluorescent proteins and calmodulin. Nature1997; 388: 882–7.
54.
SubachFVMalashkevichVNZencheckWDXiaoHFilonovGSAlmoSCVerkhushaVV. Photoactivation mechanism of PAmCherry based on crystal structures of the protein in the dark and fluorescent states. Proc Natl Acad Sci USA2009; 106: 21097–102.
55.
MaurelDComps-AgrarLBrockCRivesMLBourrierEAyoubMABazinHTinelNDurrouxTPrezeauLTrinquetEPinJP. Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to GPCR oligomerization. Nat Methods2008; 5: 561–7.
SoboleskiMROaksJHalfordWP. Green fluorescent protein is a quantitative reporter of gene expression in individual eukaryotic cells. FASEB J2005; 19: 440–2.
58.
FritzRDLetzelterMReimannAMartinKFuscoLRitsmaLPonsioenBFluriESchulte-MerkerSvan RheenenJPertzO. A versatile toolkit to produce sensitive FRET biosensors to visualize signaling in time and space. Science Signal2013; 6: rs12–rs12.
59.
MorrisMC. Fluorescent biosensors of intracellular targets from genetically encoded reporters to modular polypeptide probes. Cell Biochem Biophys2010; 56: 19–37.
60.
BairdGSZachariasDATsienRY. Circular permutation and receptor insertion within green fluorescent proteins. Proc Natl Acad Sci USA1999; 96: 11241–6.
61.
HanX. In vivo application of optogenetics for neural circuit analysis. ACS Chem Neurosci2012; 3: 577–84.
62.
BoydenESZhangFBambergENagelGDeisserothK. Millisecond-timescale, genetically targeted optical control of neural activity. Nat Neurosci2005; 8: 1263–8.
AkerboomJChenTWWardillTJTianLMarvinJSMutluSCalderonNCEspostiFBorghuisBGSunXRGordusAOrgerMBPortuguesREngertFMacklinJJFilosaAAggarwalAKerrRATakagiRKracunSShigetomiEKhakhBSBaierHLagnadoLWangSSBargmannCIKimmelBEJayaramanVSvobodaKKimDSSchreiterERLoogerLL. Optimization of a GCaMP calcium indicator for neural activity imaging. J Neurosci2012; 32: 13819–40.
67.
AtakaKPieriboneVA. A genetically targetable fluorescent probe of channel gating with rapid kinetics. Biophys J2002; 82: 509–16.
68.
SakaiRRepunte-CanonigoVRajCDKnopfelT. Design and characterization of a DNA-encoded, voltage-sensitive fluorescent protein. Eur J Neurosci2001; 13: 2314–8.
69.
MutohHPerronAAkemannWIwamotoYKnopfelT. Optogenetic monitoring of membrane potentials. Exp Physiol2011; 96: 13–8.
70.
PattersonGHLippincott-SchwartzJ. A photoactivatable GFP for selective photolabeling of proteins and cells. Science2002; 297: 1873–7.
71.
ColeNBSmithCLSciakyNTerasakiMEdidinMLippincott-SchwartzJ. Diffusional mobility of Golgi proteins in membranes of living cells. Science1996; 273: 797–801.
72.
HuCDChinenovYKerppolaTK. Visualization of interactions among bZIP and Rel family proteins in living cells using bimolecular fluorescence complementation. Mol Cell2002; 9: 789–98.
73.
NagaiTSawanoAParkESMiyawakiA. Circularly permuted green fluorescent proteins engineered to sense Ca2+. Proc Natl Acad Sci USA2001; 98: 3197–202.
74.
MiesenbockGDe AngelisDARothmanJE. Visualizing secretion and synaptic transmission with pH-sensitive green fluorescent proteins. Nature1998; 394: 192–5.
75.
MahonMJ. pHluorin2: an enhanced, ratiometric, pH-sensitive green florescent protein. Adv Biosci Biotechnol2011; 2: 132–7.
76.
GroverASchmidtBFSalterRDWatkinsSCWaggonerASBruchezMP. Genetically encoded pH sensor for tracking surface proteins through endocytosis. Angewandte Chem2012; 51: 4838–42.
77.
FisherGWFuhrmanMHAdlerSASzent-GyorgyiCWaggonerASJarvikJW. Self-checking cell-based assays for GPCR desensitization and resensitization. J Biomol Screen2014; 19: 1220–6.
78.
MinamikawaTSriratanaAWilliamsDABowserDNHillJSNagleyP. Chloromethyl-X-rosamine (MitoTracker Red) photosensitises mitochondria and induces apoptosis in intact human cells. J Cell Sci1999; 112: 2419–30.
79.
TaylorDLSalmonEDBasic fluorescence microscopy. In: WangYLTaylorDL (eds). Methods in cell biology. Volume 29 Fluorescence microscopy of living cells in culture. Part A, San Diego, CA: Academic Press, 1989, pp. 207–37.
80.
YangTBurrowsCParkJH. Development of a doxycycline-inducible lentiviral plasmid with an instant regulatory feature. Plasmid2014; 72: 29–35.
81.
GossenMBujardH. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA1992; 89: 5547–51.
82.
ZhengCBaumBJ. Evaluation of promoters for use in tissue-specific gene delivery. Methods Mol Biol2008; 434: 205–19.
83.
KimTKEberwineJH. Mammalian cell transfection: the present and the future. Anal Bioanal Chem2010; 397: 3173–8.
84.
KobayashiNRivas-CarrilloJDSoto-GutierrezAFukazawaTChenYNavarro-AlvarezNTanakaN. Gene delivery to embryonic stem cells. Birth Defects Res Part C Embryo Today Rev2005; 75: 10–8.
85.
SakumaTBarryMAIkedaY. Lentiviral vectors: basic to translational. Biochem J2012; 443: 603–18.
86.
CroninJZhangXYReiserJ. Altering the tropism of lentiviral vectors through pseudotyping. Curr Gene Ther2005; 5: 387–98.
87.
GajTGersbachCABarbasCF3rd. ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol2013; 31: 397–405.
88.
HsuPDLanderESZhangF. Development and applications of CRISPR-Cas9 for genome engineering. Cell2014; 157: 1262–78.
89.
PhillipsMITangYL. Genetic modification of stem cells for transplantation. Adv Drug Deliv Rev2008; 60: 160–72.
90.
HowdenSEThomsonJA. Gene targeting of human pluripotent stem cells by homologous recombination. Methods Mol Biol2014; 1114: 37–55.
91.
Huebsch N, Loskill P, Mandegar MA, Marks NC, Sheehan AS, Ma Z, Mathur AA, Nguyen TN, Yoo JC, Judge LM, Spencer CI, Chukka A, Russell CR, So PL, Conklin BR, Healy KE. Automated video-based analysis of contractility and calcium flux in human iPS-derived cardiomyocytes cultured over different spatial scales. Tissue Eng Part C Methods 2014. Epub ahead of print.
92.
SoldnerFLaganiereJChengAWHockemeyerDGaoQAlagappanRKhuranaVGolbeLIMyersRHLindquistSZhangLGuschinDFongLKVuBJMengXUrnovFDRebarEJGregoryPDZhangHSJaenischR. Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell2011; 146: 318–31.
93.
HockemeyerDWangHKianiSLaiCSGaoQCassadyJPCostGJZhangLSantiagoYMillerJCZeitlerBCheroneJMMengXHinkleySJRebarEJGregoryPDUrnovFDJaenischR. Genetic engineering of human pluripotent cells using TALE nucleases. Nat Biotechnol2011; 29: 731–4.
94.
HouZZhangYPropsonNEHowdenSEChuLFSontheimerEJThomsonJA. Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis. Proc Natl Acad Sci USA2013; 110: 15644–9.
95.
SanderJDJoungJK. CRISPR-Cas systems for editing, regulating and targeting genomes. Nat Biotechnol2014; 32: 347–55.
96.
ChoSWKimSKimYKweonJKimHSBaeSKimJS. Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases. Genome Res2014; 24: 132–41.
97.
ShalemOSanjanaNEHartenianEShiXScottDAMikkelsenTSHecklDEbertBLRootDEDoenchJGZhangF. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science2014; 343: 84–7.
98.
RanFAHsuPDLinCYGootenbergJSKonermannSTrevinoAEScottDAInoueAMatobaSZhangYZhangF. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell2013; 154: 1380–9.
99.
JaeschkeHGoresGJCederbaumAIHinsonJAPessayreDLemastersJJ. Mechanisms of hepatotoxicity. Toxicol Sci2002; 65: 166–76.
100.
ZhaoHJosephJFalesHMSokoloskiEALevineRLVasquez-VivarJKalyanaramanB. Detection and characterization of the product of hydroethidine and intracellular superoxide by HPLC and limitations of fluorescence. Proc Natl Acad Sci USA2005; 102: 5727–32.
101.
Drasdo D, Bode J, Dahmen U, Dirsch O, Dooley S, Gebhardt R, Ghallab A, Godoy P, Haussinger D, Hammad S, Hoehme S, Holzhutter HG, Klingmuller U, Kuepfer L, Timmer J, Zerial M, Hengstler JG. The virtual liver: state of the art and future perspectives. Arch Toxicol 2014;88:2071–2075.
102.
ChenJRogersSCKavdiaM. Analysis of kinetics of dihydroethidium fluorescence with superoxide using xanthine oxidase and hypoxanthine assay. Ann Biomed Eng2013; 41: 327–37.
103.
JuCReillyT. Role of immune reactions in drug-induced liver injury (DILI). Drug Metab Rev2012; 44: 107–15.
104.
PorterAGJanickeRU. Emerging roles of caspase-3 in apoptosis. Cell Death Differ1999; 6: 99–104.
105.
MeyerLHKarawajewLSchrappeMLudwigWDDebatinKMStahnkeK. Cytochrome c-related caspase-3 activation determines treatment response and relapse in childhood precursor B-cell ALL. Blood2006; 107: 4524–31.
106.
KuznetsovAVMargreiterRAmbergerASaksVGrimmM. Changes in mitochondrial redox state, membrane potential and calcium precede mitochondrial dysfunction in doxorubicin-induced cell death. Biochim Biophys Acta2011; 1813: 1144–52.
107.
SouslovaEABelousovVVLockJGStrombladSKasparovSBolshakovAPPinelisVGLabasYALukyanovSMayrLMChudakovDM. Single fluorescent protein-based Ca2+ sensors with increased dynamic range. BMC Biotechnol2007; 7: 37–37.
108.
LederLStarkWFreulerFMarshMMeyerhoferMStettlerTMayrLMBritanovaOVStrukovaLAChudakovDMSouslovaEA. The structure of Ca2+ sensor Case16 reveals the mechanism of reaction to low Ca2+ concentrations. Sensors2010; 10: 8143–60.
109.
KimJAHanEEunCJTakYKSongJM. Real-time concurrent monitoring of apoptosis, cytosolic calcium, and mitochondria permeability transition for hypermulticolor high-content screening of drug-induced mitochondrial dysfunction-mediated hepatotoxicity. Toxicol Lett2012; 214: 175–81.
110.
ShcherboDSouslovaEAGoedhartJChepurnykhTVGaintzevaAShemiakinaIIGadellaTWLukyanovSChudakovDM. Practical and reliable FRET/FLIM pair of fluorescent proteins. BMC Biotechnol2009; 9: 24–24.
111.
SubachOMGundorovISYoshimuraMSubachFVZhangJGruenwaldDSouslovaEAChudakovDMVerkhushaVV. Conversion of red fluorescent protein into a bright blue probe. Chem Biol2008; 15: 1116–24.
112.
BovaMPTamDMcMahonGMattsonMN. Troglitazone induces a rapid drop of mitochondrial membrane potential in liver HepG2 cells. Toxicol Lett2005; 155: 41–50.
113.
SzkolnickaDFarnworthSLLucendo-VillarinBStorckCZhouWIredaleJPFlintOHayDC. Accurate prediction of drug-induced liver injury using stem cell-derived populations. Stem Cells Translat Med2014; 3: 141–8.
114.
TaylorDLDeBiasioRLaRoccaGPaneDPostPKolegaJGiulianoKBurtonKGoughBDowAYuJWaggonerASFarkasD. Potential of machine-vision light microscopy in toxicologic pathology. Toxicol Pathol1994; 22: 145–59.
115.
QuatresousELegrandCPouvreauS. Mitochondria-targeted cpYFP: pH or superoxide sensor?J Gen Physiol2012; 140: 567–70.
116.
Wei-LaPierreLGongGGerstnerBJDucreuxSYuleDIPouvreauSWangXSheuSSChengHDirksenRTWangW. Respective contribution of mitochondrial superoxide and pH to mitochondria-targeted circularly permuted yellow fluorescent protein (mt-cpYFP) flash activity. J Biol Chem2013; 288: 10567–77.
117.
PerrySWNormanJPBarbieriJBrownEBGelbardHA. Mitochondrial membrane potential probes and the proton gradient: a practical usage guide. BioTechniques2011; 50: 98–115.
118.
KremersGJGilbertSGCranfillPJDavidsonMWPistonDW. Fluorescent proteins at a glance. J Cell Sci2011; 124: 157–60.
119.
ShanerNCSteinbachPATsienRY. A guide to choosing fluorescent proteins. Nat Methods2005; 2: 905–9.
120.
SampleVNewmanRHZhangJ. The structure and function of fluorescent proteins. Chem Soc Rev2009; 38: 2852–64.
121.
LlopisJMcCafferyJMMiyawakiAFarquharMGTsienRY. Measurement of cytosolic, mitochondrial, and Golgi pH in single living cells with green fluorescent proteins. Proc Natl Acad Sci USA1998; 95: 6803–8.
122.
HessSTHeikalAAWebbWW. Fluorescence photoconversion kinetics in novel green fluorescent protein pH sensors (pHluorins). J Phys Chem B2004; 108: 10138–48.
123.
KerppolaTK. Visualization of molecular interactions by fluorescence complementation. Nat Rev Mol Cell Biol2006; 7: 449–56.
WattsSDSuchlandKLAmaraSGIngramSL. A sensitive membrane-targeted biosensor for monitoring changes in intracellular chloride in neuronal processes. PLoS One2012; 7: e35373–e35373.
AkerboomJCarreras CalderonNTianLWabnigSPriggeMToloJGordusAOrgerMBSeveriKEMacklinJJPatelRPulverSRWardillTJFischerESchulerCChenTWSarkisyanKSMarvinJSBargmannCIKimDSKuglerSLagnadoLHegemannPGottschalkASchreiterERLoogerLL. Genetically encoded calcium indicators for multi-color neural activity imaging and combination with optogenetics. Front Mol Neurosci2013; 6: 2–2.
128.
FisherGWAdlerSAFuhrmanMHWaggonerASBruchezMPJarvikJW. Detection and quantification of beta2AR internalization in living cells using FAP-based biosensor technology. J Biomol Screen2010; 15: 703–9.
129.
UedaHDongJ. From fluorescence polarization to Quenchbody: recent progress in fluorescent reagentless biosensors based on antibody and other binding proteins. Biochim Biophys Acta2014; 1844: 1951–9.
LosGVEncellLPMcDougallMGHartzellDDKarassinaNZimprichCWoodMGLearishROhanaRFUrhMSimpsonDMendezJZimmermanKOttoPVidugirisGZhuJDarzinsAKlaubertDHBulleitRFWoodKV. HaloTag: a novel protein labeling technology for cell imaging and protein analysis. ACS Chem Biol2008; 3: 373–82.
132.
JungDMinKJungJJangWKwonY. Chemical biology-based approaches on fluorescent labeling of proteins in live cells. Mol Biosyst2013; 9: 862–72.
133.
ChenITingAY. Site-specific labeling of proteins with small molecules in live cells. Curr Opin Biotechnol2005; 16: 35–40.
TangJBGoellnerEMWangXHTrivediRNSt CroixCMJelezcovaESvilarDBrownARSobolRW. Bioenergetic metabolites regulate base excision repair-dependent cell death in response to DNA damage. Mol Cancer Res2010; 8: 67–79.
136.
DunnJCTompkinsRGYarmushML. Long-term in vitro function of adult hepatocytes in a collagen sandwich configuration. Biotechnol Prog1991; 7: 237–45.
137.
TourovskaiaAFauverMKramerGSimonsonSNeumannT. Tissue-engineered microenvironment systems for modeling human vasculature. Exp Biol Med2014; 239: 1264–71.
